Feed Preview

Inosine: Parkinson's Disease

Inosine: Parkinson's Disease diagram by StudioMolekuul, Shutterstock
StudioMolekuul, Shutterstock

Parkinson’s disease (PD) is a progressive neurodegenerative disorder that affects movement. Drug Inosine is proposed to slow progression of this disease. Here is the latest research on Inosine in PD.

Top 20 most recent papers
Science Translational Medicine

APOE4 exacerbates α-synuclein pathology and related toxicity independent of amyloid

Science Translational MedicineFebruary 7, 2020
Na ZhaoGuojun Bu
26
1
Nucleic Acids Research

Deletion of Endonuclease V suppresses chemically induced hepatocellular carcinoma

Nucleic Acids ResearchFebruary 22, 2020
Xiang Yi KongIngrun Alseth
7
Nucleic Acids Research

Broadly applicable oligonucleotide mass spectrometry for the analysis of RNA writers and erasers in vitro

Nucleic Acids ResearchFebruary 22, 2020
Felix HagelskampStefanie Kellner
1
Movement Disorders : Official Journal of the Movement Disorder Society

Randomized, Controlled Trial of Exercise on Objective and Subjective Sleep in Parkinson's Disease

Movement Disorders : Official Journal of the Movement Disorder SocietyFebruary 25, 2020
Amy W AmaraMarcas M Bamman
The Pediatric Infectious Disease Journal

Microarray Analysis of Group B Streptococci Causing Invasive Neonatal Early- and Late-Onset Infection

The Pediatric Infectious Disease JournalFebruary 25, 2020
Katharina ZürnReinhard Berner
Disability and Rehabilitation

Effectiveness of Tai Chi for health promotion for adults with health conditions: a scoping review of Meta-analyses

Disability and RehabilitationFebruary 20, 2020
Kobena EaswaranDoreen J Bartlett
Journal of Parkinson's Disease

Quantitative Profiling of Synuclein Species: Application to Transgenic Mouse Models of Parkinson's Disease

Journal of Parkinson's DiseaseFebruary 22, 2020
Serena SinghMari L DeMarco
3
Annals of Indian Academy of Neurology

Serum B12, Homocysteine Levels, and their Effect on Peripheral Neuropathy in Parkinson's Disease: Indian Cohort

Annals of Indian Academy of NeurologyFebruary 15, 2020
Neeharika L MathukumalliRupam Borgohain
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology

Diagnostic yield of hypertrophic cardiomyopathy in first-degree relatives of decedents with idiopathic left ventricular hypertrophy

Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of CardiologyFebruary 5, 2020
Gherardo FinocchiaroSanjay Sharma
81
Movement Disorders Clinical Practice

Nosology and Phenomenology of Psychosis in Movement Disorders

Movement Disorders Clinical PracticeFebruary 20, 2020
Malco RossiMarcelo Merello
12
Neurology. Genetics

Analysis of common and rare VPS13C variants in late-onset Parkinson disease

Neurology. GeneticsFebruary 12, 2020
Uladzislau RudakouZiv Gan-Or
8
1
1
Journal of Parkinson's Disease

Well Water and Parkinson's Disease in Medicare Beneficiaries: A Nationwide Case-Control Study

Journal of Parkinson's DiseaseFebruary 22, 2020
Maya R SilverSusan Searles Nielsen
3
Annals of Nuclear Medicine

The role of epsilon phenotype in brain glucose consumption in Alzheimer's disease

Annals of Nuclear MedicineFebruary 5, 2020
Maria RicciOrazio Schillaci
1
Zhonghua nei ke za zhi

Treatment of postprandial discomfort syndrome in the elderly: a multi-centered prospective randomized controlled clinical study

Zhonghua nei ke za zhiFebruary 20, 2020
G S WangCommittee of Geriatric Gastroenterology, Chinese Society of Gastroenterology

See more papers from this feed

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/inosine-parkinsons-disease/802045dd-a370-4152-9fdc-c13481caa2f4